AAAhmed S. Abdulhamid

Ahmed S. Abdulhamid

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ahmed S. Abdulhamid has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Mohammed S. Alomari

    College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia

    5 shared publications
  • Abdullah A. Ghaddaf

    College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia

    4 shared publications
  • Abdullah Alsharif

    College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia

    3 shared publications
  • Amin Zagzoog

    College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia

    2 shared publications
  • Atif Al-Qubbany

    College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia

    2 shared publications
  • Fahad Almehmadi

    College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia

    2 shared publications

Latest Publications

  • Spinocerebellar Ataxia Type 35 Presenting with Dysphagia in a Patient from Saudi Arabia: A Case Report and Literature Review

    by Ahmed Attar, Ahmed S. Abduhamid, Mumen H. Halabi, Abdulrahman Bahalaq, Afnan Sibyani, Muhammad Ejaz Ahmed, Yasser Aladdin

    Mutations in the transglutaminase 6 gene (TGM6) are associated with spinocerebellar ataxia type 35 (SCA35), and cases have been reported across diverse ethnic groups. We report the first documented case of SCA35 in Saudi Arabia, together with a focused literature review. A 35-year-old Saudi man presented to a neurology clinic with severe gait instability following nonspecific symptoms, including unintentional weight loss, dysphagia, abdominal pain, and intermittent diplopia. No family history of ataxia or similar neurological disease was noted. The condition progressed with neuropsychiatric manifestations (adjustment disorder, generalized myalgia, fibromyalgia) and upper motor neuron and extrapyramidal signs. He was admitted for further evaluation. A comprehensive diagnostic work-up, including cerebrospinal fluid studies, multiplex polymerase chain reaction, and nerve conduction studies, ruled out celiac disease, Wilson’s disease, and demyelinating diseases. Brain and full-spine magnetic resonance imaging showed no cerebellar atrophy or spinal cord abnormalities. Whole-exome sequencing identified a heterozygous splice-site mutation in TGM6 (c.850 + 1G > A), consistent with autosomal dominant SCA35. To our knowledge, this is the first reported case of SCA35 in the Middle East. This case underscores the challenges in diagnosing this condition, as patients may present with atypical features, such as dysphagia. Our findings enhance the current understanding of the epidemiology, clinical manifestations, and genetic landscape of SCA35 to improve the diagnosis and management of this rare disorder.

  • Open Access

    Transcanalicular laser-assisted and external dacryocystorhinostomy anatomical and functional success in primary acquired nasolacrimal duct obstruction: systematic review and meta-analysis

    by Khalid W. Helmi, Ahmed S. Abdulhamid, Mohammed S. Alomari, Ali S. Alsudais, Badran S. Alqurashi, Abdullah Alsharif, Abdulrahman H. Alzahrani, Abdulrahman M. Bahalaq, Mohammed F. Qutub, Hashem S. Almarzouki

    Primary acquired nasolacrimal duct obstruction (PANDO) is a condition in which tear ducts are blocked, leading to epiphora and dacryocystitis. This systematic review and meta-analysis aimed to measure the ability of transcanalicular dacryocystorhinostomy (TC-DCR) as an alternative approach to PANDO compared to traditional external dacryocystorhinostomy (EX-DCR). Our search included Embase, Medline, and the Cochrane Central Register of Controlled Trials (CENTRAL). We included only observational studies, randomized controlled trials (RCTs), and quasi-experimental studies that compared TC-DCR and EX-DCR. The outcomes measured were anatomical and functional success rates, intraoperative complications, postoperative complications, and surgical time. Statistically significant results were determined as a p value of less than 0.05; thus, a confidence interval of 95% was used. Dichotomous outcomes were reported via risk ratios (RR), whereas continuous outcomes were reported using standardized mean differences (SMD). There was a statistically significant difference in anatomical success (RR = 0.84, 95% CI 0.72–0.97; P = 0.02), favoring EX-DCR; functional success (RR = 0.87, 95% CI 0.78–0.97; P = 0.01), favoring EX-DCR; operative (OR) time (SMD = -2.42, 95% CI -2.92 – -1.91; P < 0.00001) favoring TC-DCR; and intraoperative complications (RR = 0.16, 95% CI 0.06–0.43; P = 0.0003), favoring TC-DCR. Moreover, the subgroup analysis comparing single-diode TC-DCR to EX-DCR revealed a statistically significant difference in terms of anatomical success and functional success; however, the comparison of multidiode TC-DCR to EX-DCR revealed no statistically significant difference. More research should be conducted to compare the anatomical and functional success of muli-diode TC-DCR with EX-DCR because the analysis performed comparing them revealed no statistical significance.


  • Antibiotics efficacy in clinical and microbiological cure of uncomplicated urinary tract infection: a systematic review and network meta-analysis

    by Mohammed F. Hadidi, Nawaf Alhamami, Mohammed Alhakami, Ahmed S. Abdulhamid, Abdullah Alsharif, Mohammed S. Alomari, Yasir A. Alghamdi, Samirah Alshehri, Abdullah A. Ghaddaf, Faisal M. Alsenani, et al.

    Purpose Fosfomycin has been used more frequently in managing uncomplicated urinary tract infections (UTIs) due to decreased compliance and increased multidrug-resistant bacteria. The aim of this network meta-analysis was to assess the efficacy of Fosfomycin compared to Nitrofurantoin, Trimethoprim–Sulfamethoxazole (TMP-SMX), and Ciprofloxacin in terms of clinical and microbiological cure alongside with other measurements. Materials and methods We searched MEDLINE, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL). We included randomized control trials (RCTs) with uncomplicated UTI patients who received Fosfomycin, Nitrofurantoin, TMP-SMX, or Ciprofloxacin and reported the clinical or microbiological cure. We used Cochrane Risk of Bias Assessment Tool to assess the included studies’ quality. R-software was used for all statistical analysis. We ranked all antibiotics using the netrank function which yielded P scores. Frequentist network meta-analysis was used to assess the efficacy of all outcomes. Results We included 13 RCTs with a total number of 3856 patients that showed Fosfomycin ranked the highest among the other antibiotics with respect to clinical cure (P-score = 0.99) and microbiological cure (P-score = 0.99) while Ciprofloxacin ranked the lowest (P-score = 0.11 and 0.02, respectively). Moreover, Ciprofloxacin yielded the highest relapse rate (P-score = 1), whereas TMP-SMX had the lowest relapse rate (P-score = 0.07). As for the adverse events, Ciprofloxacin demonstrated the highest adverse events as opposed to Fosfomycin (P-score = 0.98 and 0.05, respectively). Conclusion The network meta-analysis demonstrated that Fosfomycin is the most effective antibiotic in treating uncomplicated UTIs with respect to clinical cure, microbiological cure, and adverse events profile.


  • Comparison of immobilization periods following open reduction and internal fixation of distal radius fracture: A systematic review and meta-analysis

    by Abdullah A Ghaddaf, Ahmed S Abdulhamid, Mohammed S Alomari, Mohammed S Alquhaibi, Abdulaziz A Alshehri, Mohammed S Alshehri


  • Open Access

    Correction to: Modified valsalva versus standard valsalva for cardioversion of supraventricular tachycardia: systematic review and meta-analysis

    by Ahmed S. Abdulhamid, Fahad Almehmadi, Abdullah A. Ghaddaf, Mohammed S. Alomari, Amin Zagzoog, Atif Al-Qubbany

    A correction to this paper has been published: https://doi.org/10.1186/s42444-021-00034-y

  • Open Access

    Modified valsalva versus standard valsalva for cardioversion of supraventricular tachycardia: systematic review and meta-analysis

    by Ahmed S. Abdulhamid, Fahad Almehmadi, Abdullah A. Ghaddaf, Mohammed S. Alomari, Amin Zagzoog, Atif Al-Qubbany

    Background: Supraventricular tachycardia (SVT) is a major cause of emergency room visits where vagal maneuver is used as first-line therapy. The valsalva maneuver (VM) is proven to be safe and, to some extent, effective in terminating SVT episodes. We aimed to compare the standard VM (SVM) to the modified valsalva maneuver (MVM). We hypothesized that MVM is more effective in terminating SVT episodes and reducing the time spent in the emergency department.Methods: In this systematic review and meta-analysis, we searched Medline/PubMed, Ovid, Web of Science, and Cochrane Central Register of Controlled trials. We included only randomized controlled trials (RCTs) that compared the modified valsalva to the standard valsalva maneuver in treating SVT. Our main outcome was the termination of SVT within 1 min.Results: Four articles met the eligibility criteria of our review. Sinus rhythm was achieved 2.5 times more in the MVM group compared to the SVM group (risk ratio (RR) = 2.54, CI 1.98–3.24,P < 0.001) and thus lowered the need of intravenous SVT termination medication without any significant increase in adverse events or time spent in the emergency department.Conclusion: Our review found MVM to be more effective than the SVM in terminating SVT. This should encourage broader adoption of the MVM as a first-line vagal maneuver in subjects presenting with SVT in the emergency room.